{"id":"W3165898648","doi":"10.1016/j.jval.2021.04.1053","title":"PRO68 Patient-Reported Outcomes in Patients with Pemphigus Vulgaris Treated with Rituximab in the Phase 3 PEMPHIX Study","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Pemphigus vulgaris; Dermatology Life Quality Index; Prednisone; Quality of life (healthcare); Gastroenterology; Adverse effect; Dermatology; Disease; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001574856,0.0004826417,0.0008992004,0.0003603787,0.0003099943,0.000932636,0.0004042826,0.0007909822,0.0008393884],"category_scores_gemma":[0.002477405,0.0002019971,0.001272172,0.0006179544,0.0002521382,0.0006885949,0.0005562856,0.0009965778,0.0001613358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000428016,"about_ca_system_score_gemma":0.0003017707,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007418095,"about_ca_topic_score_gemma":0.001039016,"domain_scores_codex":[0.9989831,0.0005777638,0.00007698112,0.00009919085,0.0001176582,0.0001453082],"domain_scores_gemma":[0.9981621,0.0004022663,0.0009548442,0.00006724273,0.000129008,0.0002845172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.07039826,0.001487601,0.8910447,0.0005675685,0.006744106,0.0003362417,0.0002254208,0.0007892757,0.00177393,0.0002215923,0.001630249,0.02478097],"study_design_scores_gemma":[0.007880729,0.01134016,0.9735835,0.0001230615,0.003177509,0.0005294916,0.0002276439,0.0006625482,0.0003530784,0.000202881,0.001875917,0.00004358554],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959716,0.002517332,0.0000623304,0.0001531614,0.00002859256,0.00003723228,0.0006020191,0.000003720032,0.0006238666],"genre_scores_gemma":[0.9977348,0.0006410594,0.00008527299,0.0001243993,0.00006143032,0.00006122678,0.001051668,0.00000201151,0.0002382841],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001574856,"threshold_uncertainty_score":0.008328736,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02464586973999548,"score_gpt":0.3074965499189303,"score_spread":0.2828506801789348,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}